MANAGEMENT ASPECTS OF CHILDREN'S HEALTH: DYSPLASTIC-DEPENDENT PATHOLOGY OF THE BRONCHOPULMONARY SYSTEM AND ECOLOGICAL HETEROGENEITY OF THE ENVIRONMENT
DOI:
https://doi.org/10.34921/amj.2022.1.023Keywords:
innovative approaches, public health, children's health, ecological factorsAbstract
Population stratification of the pediatric population was performed in the study, taking into account a set of regional-ecological factors relevant for the assessment of the health of children with dysplastic-dependent pathology of the bronchopulmonary system. The study was conducted using methods of systematic population modeling of a multi-factorial public health system under the influence of regional and ecologic factors. For each of the 30 environmental factors we have studied, its prognostic value, pathometric and sanologic value have been determined, which ensured the performance of population-personalized risk assessment of the dysplastic-dependent pathology of the bronchopulmonary system.A new methodology for environmental quality assessment has been substantiated, proposed and tested, the application of which allows to determine the differentiation of regional preventive programs of bronchopulmonary dysplasia and the dysplastic-dependent pathology of the bronchopulmonary system in childhood. Personalized regional population stratification of children with bronchopulmonary dysplasia and the dysplastic-dependent pathology of the bronchopulmonary system were performed, and regional clusters (administrative districts of the regions) were identified with an alternative level of environmental quality. The use of pathometric and sanometric assessments (different levels) of environmental factors can be significant to substantiate the structure of targeted health, social, and regional environmental programs for promoting the health of the pediatric population.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Azerbaijan Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.


